Becton, Dickinson and Co
(NYSE:BDXB.PFD)
$
48.16
0.66 (1.39%)
Market Cap: -
Enterprise Value: -
PE Ratio: 48.87
PB Ratio: 2.65
GF Score: 79/100 Becton Dickinson and Co at Wells Fargo Virtual Healthcare Conference Transcript
Sep 10, 2020 / 12:40PM GMT
Release Date Price:
$52.1
(-0.50%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
We have Becton, Dickinson with us for this session. Joining us from the company are the President and CEO, Tom Polen; the CFO, Chris Reidy; and Kristen Stewart, the new Senior Vice President of Strategy and Investor Relations. I'm flattered that Kristen has made our conference, her first one.
So in terms of format, this will be a 30-minute fireside chat. Tom, Chris and Kristen, welcome, and thanks for joining us.
Thomas E. Polen
Becton, Dickinson and Company - President, CEO & Director
Good morning, Larry.
Christopher R. Reidy
Becton, Dickinson and Company - Executive VP, CFO & Chief Administrative Officer
Good morning, Larry.
Questions & Answers
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
Great. So Tom, let's start at a high level. Investors are
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot